Aug 9 |
Eli Lilly Named 'Top Pick' Following Q2 Beat, Upbeat Revenue Outlook, Morgan Stanley Says
|
Aug 9 |
What Eli Lilly, Novo Nordisk earnings show about GLP-1 sales
|
Aug 9 |
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
|
Aug 9 |
Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel revenue
|
Aug 9 |
Pharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, MRK's New Deal & Other Updates
|
Aug 9 |
Company News for Aug 9, 2024
|
Aug 9 |
Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year
|
Aug 9 |
Dividend Roundup: Prudential Financial, Progressive, Alcoa, Eli Lilly, and more
|
Aug 9 |
Eli Lilly Is Gaining on Novo Nordisk in the Obesity Race
|
Aug 9 |
Why GLP-1s can be a 'half a trillion dollar market': Tema ETF CEO
|